English | Español
Patient Daily | Mar 30, 2026

Study finds walking patterns may help distinguish Lewy body dementia from Parkinson’s disease
Patient Daily | Mar 30, 2026

Gilead announces $2.1 billion acquisition of Ouro Medicines and other industry updates
Patient Daily | Mar 30, 2026

UCB announces $2 billion biologics manufacturing facility in Georgia
Patient Daily | Mar 30, 2026

RA Capital Management launches new SPAC with focus on Chinese biotech startups
Patient Daily | Mar 30, 2026

Merck to acquire Terns Pharmaceuticals and leukemia drug for $6.7 billion
Patient Daily | Mar 30, 2026

Trace Neuroscience pursues new ALS treatment targeting UNC13A protein deficiency
Patient Daily | Mar 30, 2026

Novo Nordisk's oral Wegovy launch draws attention as access barriers persist for obesity drugs
Patient Daily | Mar 30, 2026

Karyopharm reports mixed Phase 3 results for Xpovio in myelofibrosis study

Trending
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Researchers identify artemin as marker and target in feline osteoarthritis